<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131782">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01386359</url>
  </required_header>
  <id_info>
    <org_study_id>IM103-076</org_study_id>
    <nct_id>NCT01386359</nct_id>
  </id_info>
  <brief_title>Evaluating Nulojix (Belatacept) Long-Term Safety in Transplant</brief_title>
  <acronym>ENLIST</acronym>
  <official_title>Evaluating Nulojix Long-Term Safety in Transplant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Parexel</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Bristol-Myers Squibb</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To describe how Nulojix (belatacept) is used and to determine how often Post-Transplant
      Lymphoproliferative Disorder (PTLD), Central Nervous System (CNS) PTLD and Progressive
      Multifocal Leukoencephalopathy (PML), rare and serious complications of transplant
      treatment, occur in patients taking Nulojix (belatacept) in a real-world setting.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Time Perspective: Prospective for the majority of patients who are enrolled at the time they
      begin Nulojix (belatacept) treatment. Retrospective for any patients receiving Nulojix
      (belatacept) prior to enrollment into ENLiST Registry
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">April 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence rate of confirmed PTLD in US adult de novo Epstein Barr Virus (EBV)-seropositive kidney transplant recipients treated with Nulojix (belatacept) in clinical practice</measure>
    <time_frame>Every 6 months for up to 72 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence rate of confirmed CNS PTLD in US adult de novo Epstein Barr Virus (EBV)-seropositive kidney transplant recipients treated with Nulojix (belatacept) in clinical practice</measure>
    <time_frame>Every 6 months for up to 72 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence rate of PML in confirmed PML in US adult de novo Epstein Barr Virus (EBV)-seropositive kidney transplant recipients treated with Nulojix (belatacept) in clinical practice</measure>
    <time_frame>Every 6 months for up to 72 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Demographic, clinical and treatment characteristics of patients receiving Nulojix (belatacept)</measure>
    <time_frame>Every 6 months for up to 72 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of graft survival observed in the Nulojix (belatacept) treated patients</measure>
    <time_frame>Every 6 months for up to 72 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rates of patient survival observed in the Nulojix (belatacept) treated patients</measure>
    <time_frame>Every 6 months for up to 72 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence rate of confirmed PTLD and confirmed CNS PTLD by baseline CMV serostatus among Nulojix (belatacept) treated population</measure>
    <time_frame>Every 6 months for up to 72 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence rates of total reported PTLD, reported CNS PTLD and reported PML in adult de novo EBV seropositive kidney transplant recipients treated with Nulojix (belatacept)</measure>
    <time_frame>Every 6 months for up to 72 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence rates of total reported PTLD and of total reported CNS PTLD by baseline CMV serostatus among Nulojix (belatacept) treated patients</measure>
    <time_frame>Every 6 months for up to 72 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1130</enrollment>
  <condition>Kidney Transplantation</condition>
  <arm_group>
    <arm_group_label>Adult de novo EBV-seropositive kidney-transplant recipients</arm_group_label>
    <description>Adult de novo EBV-seropositive kidney-transplant recipients treated with Nulojix (belatacept)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>No Intervention</intervention_name>
    <description>No Intervention. Subjects are previously treated with Nulojix (belatacept)</description>
    <arm_group_label>Adult de novo EBV-seropositive kidney-transplant recipients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All adult de novo EBV-seropositive kidney transplant recipients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        For more information regarding BMS clinical trial participation, please visit
        www.BMSStudyConnect.com.

        Inclusion Criteria:

          -  Adult kidney transplant recipient (age ≥18 years at time of transplant)

          -  Kidney-only transplant recipient

          -  Positive EBV serostatus

             a) EBV serostatus negative or unknown included per the investigator discretion

          -  Received first dose of Nulojix (Belatacept) within ≤ 14 days of renal transplant

          -  Received first dose of Nulojix (Belatacept) as part of normal clinical care (i.e. not
             as part of a clinical trial)

        Exclusion Criteria:

          -  Received Nulojix (belatacept) for non kidney transplants

          -  &lt;18 years of age at time of transplant

          -  Received first dose of Nulojix (belatacept) as an assigned study drug under a
             clinical trial protocol

          -  EBV-serostatus negative or unknown patients, except by investigator decision

          -  Patient who did not receive Belatacept for de novo treatment

          -  Recipient of concurrent or extant non-kidney organ transplant

          -  Received first dose of Nulojix (belatacept) &gt; 14 days after date of renal transplant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bristol-Myers Squibb</last_name>
    <role>Study Director</role>
    <affiliation>Bristol-Myers Squibb</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>For participation information at a USA site use a phone number below. For Site information outside USA please email:</last_name>
    <email>Clinical.Trials@bms.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>First line of email MUST contain NCT# &amp; Site#. Only sites that are recruiting have contact information at this time.</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Arizona</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of California, Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suphamai Bunnapradist, Site B0231</last_name>
      <phone>310-794-8516</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>USC University Hospital</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai Med Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stanley Jordan, Site B0220</last_name>
      <phone>310-423-2641</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Vincent Medical Center - Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>California Institute of Renal Research</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven M Steinberg, Site B0175</last_name>
      <phone>858-637-4800</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco Medical Center</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Flavio Vincenti, Site B0129</last_name>
      <phone>415-353-1322</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Colorado School of Medicine</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Denver Nephrologists</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Yale University (Yale New Haven Hospital)</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Yoo, Site B0208</last_name>
      <phone>203-785-2073</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tampa General Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Victor Bowers, Site B0107</last_name>
      <phone>813-844-5691</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Emory Healthcare - Emory University Hospital (EUH)</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Larsen, Site B0001</last_name>
      <phone>404-712-7168</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lorenzo Gallon, Site B0214</last_name>
      <phone>312-908-8342</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Illinois Mecial Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia West-Thielke, Site B0206</last_name>
      <phone>312-996-5695</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J Millis, Site B0130</last_name>
      <phone>773-834-4430</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lutheran Kidney Transplant Center</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer McComb, Site B0234</last_name>
      <phone>260-435-6272</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Iowa Clinic</name>
      <address>
        <city>Des Moines</city>
        <state>Iowa</state>
        <zip>50309</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Craig Shadur, Site B0226</last_name>
      <phone>515-241-4044</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maine Medical Center</name>
      <address>
        <city>Portland</city>
        <state>Maine</state>
        <zip>04102</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rolf Barth, Site B0136</last_name>
      <phone>410-328-7336</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Germain, Site B0224</last_name>
      <phone>413-733-9666</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Clair Nephrology Research</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>University of Minnesota Medical Center</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arthur Matas, Site B0138</last_name>
      <phone>612-625-6460</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barnes-Jewish Hospital</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63100</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Brennan, Site B0008</last_name>
      <phone>314-747-3000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sander Florman, Site B0002</last_name>
      <phone>212-241-6021</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Cohen, Site B0240</last_name>
      <phone>212-305-3273</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>New York- Presbyterian/ Weill Cornell Medical Canter</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meredith Aull, Site B0243</last_name>
      <phone>212-746-0727</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carolinas Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>The Christ Hospital Cancer Research</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steve Woodle, Site B0109</last_name>
      <phone>513-558-0046</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Integris Baptist Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose-Marie El-Amm, Site B0232</last_name>
      <phone>405-949-3816</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Penn State Milton S. Hershey Medical Center</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zakiyah Kadry, Site B0244</last_name>
      <phone>717-531-5901</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Univ of Virginia HSC</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Swedish Medical Center</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nelson Goes, Site B0174</last_name>
      <phone>206-386-3660</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Bresnahan, Site B0189</last_name>
      <phone>414-805-9050</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.bms.com/clinical_trials/Pages/home.aspx</url>
    <description>BMS Clinical Trials Disclosure</description>
  </link>
  <link>
    <url>http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx</url>
    <description>Investigator Inquiry form</description>
  </link>
  <link>
    <url>http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm</url>
    <description>For FDA Safety Alerts and Recalls refer to the following link</description>
  </link>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 10, 2017</lastchanged_date>
  <firstreceived_date>June 28, 2011</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Abatacept</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
